ATAP Advocates
Two Organizations Join Alliance for Transparent & Affordable Prescriptions
Today, the North Carolina Rheumatology Association (NCRA) and the U.S. Pain Foundation became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.
The Center for Biosimilars
PBMs: The Biosimilar Blockade
By Angus Worthing, MD, FACR, FACP
With 5 rheumatology biosimilars already approved by the FDA, and dozens more in the pipeline, the landscape of the rheumatology drug market is on the cusp of a major shift. Biosimilars were created to bring notoriously expensive biologic drugs to patients at lower prices. In theory, they increase access to life-changing, even life-saving, treatments. As a practicing rheumatologist in downtown Washington, DC, I observe firsthand the power of biologics to bring relief to patients suffering from crippling diseases of the joints.
ATAP Advocates
Rheumatology Groups Join Alliance for Transparent & Affordable Prescriptions
The Association of Women in Rheumatology (AWIR), National Organization of Rheumatology Managers (NORM), and Rheumatology Nurses Society (RNS) announced today that they have joined the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.
atap advocates
State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions
The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.
Business wire
Leading Health Organizations Announce Launch of Alliance for Transparent & Affordable Prescriptions
Health leaders today announced the launch of the Alliance for Transparent & Affordable Prescriptions (ATAP), a coalition of provider and patient groups concerned about the practices of pharmacy benefit managers (PBMs) driving up drug costs.
Tallahassee Democrat
Levin: Patients deserve access to the right meds
By Dr. Robert Levin, President of the Florida Society of Rheumatology
Over my 28 years as a practicing rheumatologist, I have progressively been denied my authority to prescribe the best medicines for my patients.The problem is a process called “step therapy,” which allows insurance plans to force physicians to prescribe less effective – and cheaper – drugs before they can use the medications they had in mind all along. This is a bad idea, and the Florida Legislature should correct it immediately.